Challenging Second Half of 2023 for Swiss Start-Ups Confirms Projections

Feb 1, 2024 | CFO-Services, Corporate Finance, H&P News

The second half of 2023 has witnessed a significant downturn in financing rounds (–34%) and funding volume (–10%) for Swiss start-ups compared to the previous year, according to the EY Startup Barometer Switzerland. This trend was anticipated in the market, and...

Have you already thought about drawing your pension?

Jan 30, 2024 | H&P News

Find out with us about the latest changes to the AHV 21 reform and how they could shape your financial future. Read the article as PDF

Hoffmann & Partner @Swiss Biotech Day

Jan 16, 2024 | H&P News

We will be at the Swiss Biotech Day 2024 in Basel on April 22-23, 2024. We are looking forward to meeting you at our booth #56.

Hoffmann & Partner advised Predictive Layer in its trade sale to TotalEnergies

Dec 12, 2023 | H&P News, M&A

Predictive Layer, the Swiss provider of forecasting solutions in the energy and commodity trading sector, was sold to TotalEnergies. Hoffmann & Partner acted as the exclusive financial advisor to the sellers. TotalEnergies will improve the performance of its...

EsoCap AG reports positive topline results from ACESO Phase II trial investigating ESO-101 in eosinophilic esophagitis (EoE)

Dec 6, 2023 | CFO-Services, Corporate Finance, H&P News

Great news! Our long-standing client EsoCap AG has unveiled impressive clinical data – another milestone on the road to groundbreaking advances in healthcare! We have proudly accompanied EsoCap as CFO partner since its inception and are thrilled to witness these...

Stille AB (publ) acquires Fehling Instruments

Nov 30, 2023 | H&P News, M&A

We advised Stille, a listed Swedish medtech company, in the acquisition of Fehling Instruments based in Germany in a joint mandate with our AICA network partner Evli Corporate Finance. Through the acquisition, Stille significantly broadens its product offering of...